Infectious events in patients with severe COVID-19: results of a cohort of patients with high prevalence of underlying immune defect

Annals of Intensive Care

Table 3 Covariates independently associated with infectious events, hospital-acquired infections and mortality in ICU patients admitted for severe COVID-19

Infectious events	Adjusted sHR	95% CI
BMI (kg/m²)	1.05	[0.99–1.108]
Mechanical ventilation	10.99	[1.48–82.04]
Hospital-acquired infections
Leukocytes (G/L)	1.07	[1.01–1.14]
Vasopressors	4.44	[1.02–19.28]
Dexamethasone	1.77	[0.83–3.78]
Mortality
Solid tumor	2.73	[1.01–7.42]
Hematological malignancy	1.99	[0.97–4.10]
SAPSII	1.04	[1.02–1.06]

BMI body mass index, CI confidence interval, SAPSII Simplified Acute Physiology Score II, sHR sub-hazard ratio